Filing Details

Accession Number:
0001144204-18-032476
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-01 17:54:13
Reporting Period:
2018-05-30
Accepted Time:
2018-06-01 17:54:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1426800 Assembly Biosciences Inc. ASMB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238325 R William Ringo C/o Assembly Biosciences, Inc.
11711 N. Meridian Street, Suite 310
Carmel IN 46032
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-01 1,000 $7.20 20,465 No 4 M Direct
Common Stock Disposition 2018-06-01 1,000 $42.47 19,465 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2018-05-30 7,500 $0.00 7,500 $42.09
Common Stock Stock Option (right to buy) Disposition 2018-06-01 1,000 $0.00 1,000 $7.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,500 2028-05-30 No 4 A Direct
50,000 2024-07-10 No 4 M Direct
Footnotes
  1. The option exercise and sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The shares of common stock underlying the option will vest upon the earlier of (i) May 30, 2019 and (ii) the date of the Issuer's 2019 annual meeting of stockholders.
  3. This option, initially representing a right to purchase 64,000 shares, became exercisable in three equal installments on July 11, 2014; July 11, 2015; and July 11, 2016.